Seattle Genetics | الدائنين التجاريين


Trade Creditors تغيير تاريخ
AbbVie USD 2.94B 2.66B 2024-12
Acadia Pharmaceuticals USD 20.1M 2M 2025-06
Agios Pharmaceuticals USD 17.53M 3.81M 2025-06
Amgen USD 18.03B 15.63B 2025-06
Astellas Pharma JPY 165.89B 21.95B 2025-06
Bayer EUR 6.04B 549M 2025-06
Biogen USD 408.4M 16.9M 2025-06
BioMarin Pharmaceutical USD 684.25M 390.5M 2025-06
Bristol-Myers Squibb USD 5.43B 1.42B 2025-06
Celldex Therapeutics USD 2.07M 1.34M 2025-06
Daiichi Sankyo JPY 518.54B 61.41B 2025-06
Eisai JPY 82.98B 8.59B 2025-06
Eli Lilly USD 4.08B 633.7M 2025-06
Exelixis USD 25.82M 17.02M 2025-07
Genmab DKK 5M 1.22M 2025-03
Gilead Sciences USD 582M 155M 2025-06
GlaxoSmithKline GBP 14.82B 329M 2025-06
Glaxosmithkline GBP 13.65B 10.19B 2025-06
Incyte USD 1.41B 1.21B 2025-06
Insmed USD 78.35M 16.95M 2025-06
MacroGenics USD 4.66M 353K 2025-06
Merck USD 4.04B 261M 2025-06
Moderna USD 175M 51M 2025-06
Novartis USD 4.51B 245M 2025-06
Pfizer USD 5.17B 74M 2025-06
Regeneron Pharmaceuticals USD 723.9M 18.4M 2025-06
Sanofi EUR 7.08B 14.54B 2025-06
Sarepta Therapeutics USD 136.7M 19.4M 2025-06
Takeda JPY 421.31B 54.23B 2025-06
Teva Pharmaceutical Industries USD 2.5B 208M 2025-06
Vertex Pharmaceuticals USD 3.71B 3.27B 2025-06
Xencor USD 18.53M 2.34M 2025-06


Seattle Genetics الدائنين التجاريين - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Sep 2025.